Dopamine Agents
Research News and Information

Saturday, November 21, 2009

Evaluating dopamine reward pathway in ADHD: clinical implications.

7 Sep 2009 CONTEXT: Attention-deficit/hyperactivity disorder (ADHD)--characterized by symptoms of inattention and hyperactivity-impulsivity--is the most prevalent childhood psychiatric disorder that frequently persists into adulthood, and there is increasing ... Read more...

Effects of donor pretreatment with dopamine on graft function after kidney transplantation: a randomized controlled trial.

7 Sep 2009 CONTEXT: Kidney graft function after transplantation can be improved through pharmacological donor pretreatment to limit organ injury from cold preservation. OBJECTIVE: To determine whether pretreatment of brain-dead donors with low-dose dopamine ... Read more...

Gold electrode incorporating corrole as an ion-channel mimetic sensor for determination of dopamine.

30 Aug 2009 Here, we report on an ion-channel mimetic sensor using self-assembly monolayers deposited onto gold electrodes for electrochemical determination of dopamine. The different compositions of the modification solution consist of corrole-SH and other ... Read more...

Latest indexed articles for 'Dopamine Agents'

These are the very latest articles for this heading:

• Evaluating dopamine reward pathway in ADHD: clinical implications. 7 Sep 2009
• Effects of donor pretreatment with dopamine on graft function after kidney transplantation: a randomized controlled trial. 7 Sep 2009
• Gold electrode incorporating corrole as an ion-channel mimetic sensor for determination of dopamine. 30 Aug 2009
• Toxic effect of methamphetamine on the retina of CD1 mice. 30 Aug 2009
• [(3)H]4-(Dimethylamino)-N-[4-(4-(2-methoxyphenyl)piperazin- 1-yl)butyl]benzamide, a selective radioligand for dopamine D(3) receptors. I. In vitro characterization. 30 Aug 2009
• Amphetamine reduces vesicular dopamine content in dexamethasone-differentiated PC12 cells only following L-DOPA exposure. 20 Aug 2009
• TRPC1 inhibits apoptotic cell degeneration induced by dopaminergic neurotoxin MPTP/MPP(+). 17 Aug 2009
• Tinnitus treatment with piribedil guided by electrocochleography and acoustic otoemissions. 30 Jul 2009
• Striatal GPR88 expression is confined to the whole projection neuron population and is regulated by dopaminergic and glutamatergic afferents. 26 Jul 2009
• MPTP administration increases plasma levels of acute phase proteins in non-human primates (Macaca fascicularis). 24 Jul 2009
• DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease - a multicentre RCT. 22 Jul 2009
• Lack of pharmacokinetic interactions between transdermal rotigotine and oral levodopa/carbidopa. 21 Jul 2009
• Identification and characterization of a novel amphioxus dopamine D-like receptor. 21 Jul 2009
• Quantification of Paraquat, MPTP, and MPP+ in brain tissue using microwave-assisted solvent extraction (MASE) and high-performance liquid chromatography-mass spectrometry. 17 Jul 2009
• Differential dopaminergic modulation of neostriatal synaptic connections of striatopallidal axon collaterals. 13 Jul 2009
• Identification of the functional core of the influenza A virus A/M2 proton-selective ion channel. 7 Jul 2009
• An involvement of BDNF and PI3-K/Akt in the anti-apoptotic effect of memantine on staurosporine-evoked cell death in primary cortical neurons. 29 Jun 2009
• Arrestin3 mediates D(2) dopamine receptor internalization. 29 Jun 2009
• Multitracer assessment of dopamine function after transplantation of embryonic stem cell-derived neural stem cells in a primate model of Parkinson's disease. 29 Jun 2009
• Reduced ventrolateral fMRI response during observation of emotional gestures related to the degree of dopaminergic impairment in Parkinson disease. 29 Jun 2009

See a longer list of these articles.

Technical information about 'Dopamine Agents'

Definition: Any drugs that are used for their effects on dopamine receptors, on the life cycle of dopamine, or on the survival of dopaminergic neurons.

Registry Number: 0

Descriptor UI: D015259

Alternative terms: Dopamine Agents; Agents, Dopamine; Dopaminergic Drugs; Drugs, Dopaminergic; Dopamine Drugs; Drugs, Dopamine; Dopaminergic Agents; Agents, Dopaminergic;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications;

Tree Number: D27.505.519.625.150; D27.505.696.577.150;

Online Note: use DOPAMINE AGENTS to search DOPAMINERGIC AGENTS 1989-94

History Note: 95; was DOPAMINERGIC AGENTS 1989-94; DOPAMINE NEURON AGENTS (NON MESH) was heading 1995

Technical Notes: GEN or unspecified; prefer specific groups or specific drugs